• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大鼠甲胎蛋白基因在肝脏中的表达调控。启动子区域和增强子元件均具有肝脏特异性,并受到地塞米松的负调控。

Regulation of the rat alpha-fetoprotein gene expression in liver. Both the promoter region and an enhancer element are liver-specific and negatively modulated by dexamethasone.

作者信息

Poliard A, Bakkali L, Poiret M, Foiret D, Danan J L

机构信息

Laboratoire d'Enzymologie du Centre National de la Recherche Scientifique, Gif-sur-Yvette, France.

出版信息

J Biol Chem. 1990 Feb 5;265(4):2137-41.

PMID:1688847
Abstract

Cis-acting elements involved in the control of rat alpha-fetoprotein gene expression in the liver and its modulation by glucocorticoid hormones were detected after transfection of chloramphenicol acetyltransferase constructs and their transient expression into two hepatoma cell lines. The proximal promoter region (-324 to -15) was found to contain all the information necessary for tissue-specific expression. It is also involved in the negative gene modulation by glucocorticoids and includes an activating regulatory domain allowing efficient expression in the HepG2 cells. Three regions within 7 kilobase pairs of the 5' extragenic sequences are capable of stimulating the chloramphenicol acetyltransferase activity driven by the alpha-fetoprotein promoter sequence. One of these regions, at about -2.5 kilobase pairs, contains a short indivisible 170-base pair DNA element that fulfills all the criteria of a tissue-specific enhancer, i.e. orientation and position independence, as well as cell-specific stimulation of gene expression driven by a homologous or heterologous promoter. The enhancing properties of this element are totally abolished by glucocorticoids. DNase I footprinting experiments indicate that several rat liver nuclear proteins interact with this enhancer element.

摘要

在氯霉素乙酰转移酶构建体转染及其在两种肝癌细胞系中的瞬时表达后,检测了参与大鼠肝脏中α-甲胎蛋白基因表达调控及其受糖皮质激素调节的顺式作用元件。发现近端启动子区域(-324至-15)包含组织特异性表达所需的所有信息。它也参与糖皮质激素的负基因调节,并包括一个激活调节域,可在HepG2细胞中实现高效表达。5'基因外序列7千碱基对内的三个区域能够刺激由α-甲胎蛋白启动子序列驱动的氯霉素乙酰转移酶活性。其中一个区域位于约-2.5千碱基对处,包含一个短的不可分割的170碱基对DNA元件,该元件满足组织特异性增强子的所有标准,即方向和位置独立性,以及由同源或异源启动子驱动的基因表达的细胞特异性刺激。糖皮质激素完全消除了该元件的增强特性。DNase I足迹实验表明,几种大鼠肝核蛋白与该增强子元件相互作用。

相似文献

1
Regulation of the rat alpha-fetoprotein gene expression in liver. Both the promoter region and an enhancer element are liver-specific and negatively modulated by dexamethasone.大鼠甲胎蛋白基因在肝脏中的表达调控。启动子区域和增强子元件均具有肝脏特异性,并受到地塞米松的负调控。
J Biol Chem. 1990 Feb 5;265(4):2137-41.
2
Enhancer and promoter elements directing activation and glucocorticoid repression of the alpha 1-fetoprotein gene in hepatocytes.在肝细胞中指导甲胎蛋白基因激活和糖皮质激素抑制的增强子及启动子元件。
Mol Cell Biol. 1988 Apr;8(4):1398-407. doi: 10.1128/mcb.8.4.1398-1407.1988.
3
Liver-specific expression of the mouse alpha-fetoprotein gene is mediated by cis-acting DNA elements.小鼠甲胎蛋白基因的肝脏特异性表达由顺式作用DNA元件介导。
Proc Natl Acad Sci U S A. 1986 Nov;83(21):8196-200. doi: 10.1073/pnas.83.21.8196.
4
Transcriptional regulation of alpha-fetoprotein expression by dexamethasone in human hepatoma cells.
J Biol Chem. 1989 Jan 5;264(1):266-71.
5
Structure, hormonal regulation, and identification of the interleukin-6- and dexamethasone-responsive element of the rat haptoglobin gene.大鼠触珠蛋白基因白细胞介素-6和地塞米松反应元件的结构、激素调节及鉴定
Mol Cell Biol. 1990 Apr;10(4):1573-83. doi: 10.1128/mcb.10.4.1573-1583.1990.
6
Cell-specific enhancer activity in a far upstream region of the human alpha-fetoprotein gene.人类甲胎蛋白基因远上游区域中的细胞特异性增强子活性。
J Biol Chem. 1987 Apr 5;262(10):4812-8.
7
Promoter and 11-kilobase upstream enhancer elements responsible for hepatoma cell-specific expression of the rat ornithine transcarbamylase gene.负责大鼠鸟氨酸转氨甲酰酶基因肝癌细胞特异性表达的启动子和11千碱基上游增强子元件。
Mol Cell Biol. 1990 Mar;10(3):1180-91. doi: 10.1128/mcb.10.3.1180-1191.1990.
8
Localization of DNA protein-binding sites in the proximal and distal promoter regions of the mouse alpha-fetoprotein gene.
J Biol Chem. 1990 Feb 25;265(6):3382-91.
9
Analysis of the mechanism of glucocorticoid-mediated down regulation of the mouse alpha-fetoprotein gene.
Biochim Biophys Acta. 1994 Jun 21;1218(2):136-44. doi: 10.1016/0167-4781(94)90002-7.
10
Characterization of a novel liver-specific enhancer in the human prothrombin gene.
J Biol Chem. 1991 Oct 5;266(28):18927-33.

引用本文的文献

1
Alpha-fetoprotein: from a diagnostic biomarker to a key role in female fertility.甲胎蛋白:从诊断生物标志物到在女性生育中发挥关键作用
Biomark Insights. 2007 Feb 7;1:82-5.
2
Expression of AFP and Rev-Erb A/Rev-Erb B and N-CoR in fetal rat liver, liver injury and liver regeneration.甲胎蛋白、Rev-Erb A/Rev-Erb B和N-CoR在胎鼠肝脏、肝损伤及肝再生中的表达
Comp Hepatol. 2006 Jul 5;5:2. doi: 10.1186/1476-5926-5-2.
3
Functional analysis of developmentally regulated chromatin-hypersensitive domains carrying the alpha 1-fetoprotein gene promoter and the albumin/alpha 1-fetoprotein intergenic enhancer.
携带甲胎蛋白基因启动子和白蛋白/甲胎蛋白基因间增强子的发育调控染色质超敏结构域的功能分析。
Mol Cell Biol. 1993 Mar;13(3):1619-33. doi: 10.1128/mcb.13.3.1619-1633.1993.
4
Members of the CAAT/enhancer-binding protein, hepatocyte nuclear factor-1 and nuclear factor-1 families can differentially modulate the activities of the rat alpha-fetoprotein promoter and enhancer.CAAT/增强子结合蛋白、肝细胞核因子-1和核因子-1家族的成员可对大鼠甲胎蛋白启动子和增强子的活性进行差异性调节。
Biochem J. 1994 Jul 1;301 ( Pt 1)(Pt 1):49-55. doi: 10.1042/bj3010049.
5
The alpha-foetoprotein proximal enhancer: localization, cell specificity and modulation by dexamethasone.甲胎蛋白近端增强子:定位、细胞特异性及地塞米松的调节作用
Nucleic Acids Res. 1990 Nov 11;18(21):6277-82. doi: 10.1093/nar/18.21.6277.
6
Molecular cloning of two C/EBP-related proteins that bind to the promoter and the enhancer of the alpha 1-fetoprotein gene. Further analysis of C/EBP beta and C/EBP gamma.与甲胎蛋白基因启动子和增强子结合的两种C/EBP相关蛋白的分子克隆。C/EBPβ和C/EBPγ的进一步分析。
Nucleic Acids Res. 1992 Jun 25;20(12):3091-8. doi: 10.1093/nar/20.12.3091.